$ACHC
Acadia Healthcare Company, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024119044 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $815.6M
YoY Change 8.7%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $518.7M
YoY Change 8.37%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.64M
YoY Change 12.7%
% of Gross Profit
Operating Expenses $668.4M
YoY Change 8.51%
Operating Profit
YoY Change
Interest Expense -$29.92M
YoY Change 44.56%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $98.57M
YoY Change -134.3%
Income Tax $27.20M
% Of Pretax Income 27.59%
Net Earnings $68.13M
YoY Change -131.29%
Net Earnings / Revenue 8.35%
Basic Earnings Per Share $0.74
Diluted Earnings Per Share $0.74
COMMON SHARES
Basic Shares Outstanding 92.89M 92.87M
Diluted Shares Outstanding 92.19M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $82.15M
YoY Change -17.53%
Cash & Equivalents $82.15M
Short-Term Investments
Other Short-Term Assets $186.0M
YoY Change -22.9%
Inventory $5.514M
Prepaid Expenses $50.71M
Receivables $383.9M
Other Receivables $22.84M
Total Short-Term Assets $652.1M
YoY Change -7.31%
LONG-TERM ASSETS
Property, Plant & Equipment $2.680B
YoY Change 24.9%
Goodwill $2.265B
YoY Change 1.75%
Intangibles $73.14M
YoY Change -0.91%
Long-Term Investments
YoY Change
Other Assets $75.12M
YoY Change 3.71%
Total Long-Term Assets $5.218B
YoY Change 12.4%
TOTAL ASSETS
Total Short-Term Assets $652.1M
Total Long-Term Assets $5.218B
Total Assets $5.870B
YoY Change 9.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $201.4M
YoY Change 34.37%
Accrued Expenses $291.7M
YoY Change -52.99%
Deferred Revenue $1.691M
YoY Change -34.58%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $71.69M
YoY Change 169.9%
Total Short-Term Liabilities $609.5M
YoY Change -29.53%
LONG-TERM LIABILITIES
Long-Term Debt $1.805B
YoY Change 33.7%
Other Long-Term Liabilities $150.5M
YoY Change 3.18%
Total Long-Term Liabilities $1.955B
YoY Change 30.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $609.5M
Total Long-Term Liabilities $1.955B
Total Liabilities $2.724B
YoY Change 7.43%
SHAREHOLDERS EQUITY
Retained Earnings $354.7M
YoY Change 379.4%
Common Stock $2.677B
YoY Change 1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.032B
YoY Change
Total Liabilities & Shareholders Equity $5.870B
YoY Change 9.81%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $68.13M
YoY Change -131.29%
Depreciation, Depletion And Amortization $37.64M
YoY Change 12.7%
Cash From Operating Activities $163.1M
YoY Change 18.38%
INVESTING ACTIVITIES
Capital Expenditures $190.2M
YoY Change 48.62%
Acquisitions
YoY Change
Other Investing Activities -$2.812M
YoY Change 116.31%
Cash From Investing Activities -$193.1M
YoY Change 49.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.90M
YoY Change -266.19%
NET CHANGE
Cash From Operating Activities 163.1M
Cash From Investing Activities -193.1M
Cash From Financing Activities 34.90M
Net Change In Cash 4.978M
YoY Change -139.51%
FREE CASH FLOW
Cash From Operating Activities $163.1M
Capital Expenditures $190.2M
Free Cash Flow -$27.11M
YoY Change -376.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001520697
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35331
dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2492228
dei Entity Address Address Line1
EntityAddressAddressLine1
6100 Tower Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
dei Entity Address City Or Town
EntityAddressCityOrTown
Franklin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37067
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
861-6000
dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
dei Trading Symbol
TradingSymbol
ACHC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92885352
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82145000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100073000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
383945000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
361451000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
185972000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
134476000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
652062000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
596000000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2679807000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266610000
CY2024Q3 us-gaap Goodwill
Goodwill
2264851000
CY2023Q4 us-gaap Goodwill
Goodwill
2225962000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73139000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73278000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2706000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6658000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
122771000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117780000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75121000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72553000
CY2024Q3 us-gaap Assets
Assets
5870457000
CY2023Q4 us-gaap Assets
Assets
5358841000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
71694000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29219000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
201379000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
156132000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
141470000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
141901000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27175000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26268000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
167782000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
532261000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
609500000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
885781000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1804825000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1342548000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54112000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1931000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
105437000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100808000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150544000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
140113000
CY2024Q3 us-gaap Liabilities
Liabilities
2724418000
CY2023Q4 us-gaap Liabilities
Liabilities
2471181000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
114521000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
105686000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91757352
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91757352
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91263989
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91263989
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
918000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
913000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2675882000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2649340000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
354718000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131721000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3031518000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2781974000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5870457000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5358841000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
815634000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
750334000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2379725000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2185938000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
9467000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8163000
us-gaap Share Based Compensation
ShareBasedCompensation
27014000
us-gaap Share Based Compensation
ShareBasedCompensation
23140000
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
428147000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
394150000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1265427000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1171960000
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
48498000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
45540000
us-gaap Professional Fees
ProfessionalFees
142236000
us-gaap Professional Fees
ProfessionalFees
130468000
CY2024Q3 us-gaap Supplies Expense
SuppliesExpense
29623000
CY2023Q3 us-gaap Supplies Expense
SuppliesExpense
27147000
us-gaap Supplies Expense
SuppliesExpense
84153000
us-gaap Supplies Expense
SuppliesExpense
79312000
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
12389000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
11731000
us-gaap Operating Lease Expense
OperatingLeaseExpense
36141000
us-gaap Operating Lease Expense
OperatingLeaseExpense
34880000
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
112137000
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
104048000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
322900000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
290798000
CY2023Q3 achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
4442000
achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
4442000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37641000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33388000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
110054000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
96969000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-29924000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20742000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-86297000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-61651000
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
394181000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
394181000
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
10459000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
11459000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
8694000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
8249000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11247000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
17187000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
26792000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
717067000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1037732000
us-gaap Costs And Expenses
CostsAndExpenses
2075854000
us-gaap Costs And Expenses
CostsAndExpenses
2291263000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98567000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-287398000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
303871000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-105325000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27199000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-71873000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72916000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-29907000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
71368000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-215525000
us-gaap Profit Loss
ProfitLoss
230955000
us-gaap Profit Loss
ProfitLoss
-75418000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3236000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2185000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7958000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3978000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
68132000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-217710000
us-gaap Net Income Loss
NetIncomeLoss
222997000
us-gaap Net Income Loss
NetIncomeLoss
-79396000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91720000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91168000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91571000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90852000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92188000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91168000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92119000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90852000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1203000
CY2023Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-48874000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7629000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
902000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2839602000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3784000
CY2023Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-2017000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7348000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
72299000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2921016000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1554000
CY2023Q3 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-843000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8163000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
382000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-217710000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2712562000
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1656000
CY2023Q4 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-798000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9149000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1676000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
57729000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2781974000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4102000
CY2024Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-5115000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8678000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
76383000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2866022000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1478000
CY2024Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-2133000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8869000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
78482000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2952718000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1609000
CY2024Q3 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-765000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9467000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
357000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
68132000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3031518000
us-gaap Profit Loss
ProfitLoss
230955000
us-gaap Profit Loss
ProfitLoss
-75418000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
110054000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
96969000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3061000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2485000
us-gaap Share Based Compensation
ShareBasedCompensation
27014000
us-gaap Share Based Compensation
ShareBasedCompensation
23140000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
56133000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-21655000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
394181000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
11459000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
8694000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3988000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1423000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20936000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40227000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3334000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
77165000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-676000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-309000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-404942000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23057000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1841000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3038000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
8681000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
17723000
achc Increase Decrease In Government Relief Funds
IncreaseDecreaseInGovernmentReliefFunds
-4442000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12992000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
346036000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
53550000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
349000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
486891000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
285410000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10227000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
633000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2935000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1925000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-533149000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-287051000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
350000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
35000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
40968000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
15938000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1518000
achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-824000
achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-45193000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
3500000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
2538000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
2972000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
3480000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
502229000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57043000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17928000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1942000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100073000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97649000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82145000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99591000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
59235000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
6766000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
4185000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
128000
achc Contingent Consideration Issued In Connection With Acquisition
ContingentConsiderationIssuedInConnectionWithAcquisition
-1500000
achc Redeemable Noncontrolling Interest Resulting From An Acquisition
RedeemableNoncontrollingInterestResultingFromAnAcquisition
6289000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
53550000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
349000
achc Number Of Facilities
NumberOfFacilities
260
CY2024Q3 achc Number Of Beds
NumberOfBeds
11300
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
38
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
68132000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-217710000
us-gaap Net Income Loss
NetIncomeLoss
222997000
us-gaap Net Income Loss
NetIncomeLoss
-79396000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91720000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91168000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91571000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90852000
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
468000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
548000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92188000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91168000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92119000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90852000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000
CY2022Q4 us-gaap Goodwill
Goodwill
2222805000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
337000
CY2023 achc Increase In Goodwill From Contribution Of Redeemable Non Controlling Interests
IncreaseInGoodwillFromContributionOfRedeemableNonControllingInterests
2820000
CY2023Q4 us-gaap Goodwill
Goodwill
2225962000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
38889000
CY2024Q3 us-gaap Goodwill
Goodwill
2264851000
CY2024Q3 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
54096000
CY2023Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
33579000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50711000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
36085000
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
28298000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
12416000
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
22836000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
22084000
CY2024Q3 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2023Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2024Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
10920000
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
11496000
CY2024Q3 us-gaap Inventory Net
InventoryNet
5514000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5300000
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1597000
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1516000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
185972000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
134476000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3544652000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3033956000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
864845000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
767346000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2679807000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266610000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
73139000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
73278000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
74270000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
74409000
CY2024Q3 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2023Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2024Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
300000
CY2023Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
300000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
4700000
CY2024Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
400000000
CY2024Q3 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
19900000
CY2024Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
19900000
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
19900000
CY2024Q3 achc Accrued Expense Current
AccruedExpenseCurrent
85652000
CY2023Q4 achc Accrued Expense Current
AccruedExpenseCurrent
80733000
CY2024Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
41986000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12486000
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
17598000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
18046000
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
10358000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7097000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1691000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2165000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1081000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2023Q4 achc Accrued Desert Hills Settlement Current
AccruedDesertHillsSettlementCurrent
393696000
CY2023Q4 achc Cost Report Payable Current
CostReportPayableCurrent
9265000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9416000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7783000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
167782000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
532261000
CY2024Q3 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
9701000
CY2023Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
10421000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1876519000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1371767000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
71694000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29219000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1804825000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1342548000
achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
10
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
CY2023 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
16530000
CY2023 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
6006000
CY2023 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5107000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
105686000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
3849000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
7958000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2972000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
114521000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12700000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2095494
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
9500000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8200000
us-gaap Share Based Compensation
ShareBasedCompensation
27000000
us-gaap Share Based Compensation
ShareBasedCompensation
23100000
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
80300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y2M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
979277
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.27
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
296340
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
78.94
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
198527
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
41.29
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
140545
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
55.95
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
936545
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
75.3
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
158120
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
45.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
73698
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
67.12
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
708727
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.58
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7848000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
392054
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M25D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6685000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.24
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.044
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2024Q3 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
6041000
CY2023Q3 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
4196000
achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
15365000
achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
6761000
CY2024Q3 achc Management Transition Costs
ManagementTransitionCosts
1490000
CY2023Q3 achc Management Transition Costs
ManagementTransitionCosts
3615000
achc Management Transition Costs
ManagementTransitionCosts
3085000
achc Management Transition Costs
ManagementTransitionCosts
14590000
CY2024Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
718000
CY2023Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
3436000
us-gaap Business Exit Costs1
BusinessExitCosts1
-1263000
us-gaap Business Exit Costs1
BusinessExitCosts1
5441000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
8249000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11247000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
17187000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
26792000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.276
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.284
CY2024Q3 ecd Trd Arr Ind Title
TrdArrIndTitle
directors or officers
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-119044-index-headers.html Edgar Link pending
0000950170-24-119044-index.html Edgar Link pending
0000950170-24-119044.txt Edgar Link pending
0000950170-24-119044-xbrl.zip Edgar Link pending
achc-20240930.htm Edgar Link pending
achc-20240930.xsd Edgar Link pending
achc-ex31_1.htm Edgar Link pending
achc-ex31_2.htm Edgar Link pending
achc-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
achc-20240930_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending